#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3888181	B	In Vitro DGAT2 Assay: For determination of IC50 values, the reactions were carried out in 384-well white Polyplates (Perkin Elmer) in a total volume of 20 uL. To 1 uL of compounds dissolved in 100% DMSO and spotted at the bottom of each well, 5 uL of 0.04% bovine serum albumin (BSA) (fatty acid free, Sigma Aldrich) was added and the mixture was incubated at room temperature for 20 minutes. To this mixture, 10 uL of hDGAT2 membrane fraction (0.01 mg/mL) diluted in 100 mM Hepes-NaOH, pH 7.4, 20 mM MgCl2 containing 200 nM methyl arachidonyl fluorophosphonate (Cayman Chemical; dried from ethyl acetate stock solution under argon gas and dissolved in DMSO as 5 mM stock) was added. After this mixture was preincubated at room temperature for 2 hours, DGAT2 reactions were initiated by the addition of 4 uL of substrates containing 30 uM [1-14C]decanoyl-CoA (custom-synthesized by Perkin Elmer, 50 mCi/mmol) and 125 uM 1,2-didecanoyl-sn-glycerol (Avanti Polar Lipids) dissolved in 12.5% acetone. The reaction mixtures were incubated at room temperature for 40 min and the reactions were stopped by addition of 5 uL of 1% H3PO4. After the addition of 45 uL MicroScint-E (Perkin-Elmer), plates were sealed with Top Seal-A covers (Perkin-Elmer) and phase partitioning of substrates and products was achieved using a HT-91100 microplate orbital shaker (Big Bear Automation, Santa Clara, Calif.). Plates were centrifuged at 2,000×g for 1 min in an Allegra 6R Centrifuge (Beckman Coulter) and then were sealed again with fresh covers before reading in a 1450 Microbeta Wallac Trilux Scintillation Counter (Perkin Elmer). DGAT2 activity was measured by quantifying the generated product [14C]tridecanoylglycerol in the upper organic phase.	Homo sapiens	212	ALA3886612	assay format	BindingDB Database
2.	ALA3888182	B	DGAT2 Cell-Based Assay: For evaluation of the effects of DGAT2 inhibitors in a cell-based setting, cryopreserved human hepatocytes (Lot QOC, Celsis, Chicago, Ill.) were thawed and plated onto type I collagen-coated plates according to the manufacturer's instructions. After 24 hours overnight recovery period, the cells were overlayed with media containing 250 ug/ml Matrigel (BD Biosciences, San Jose, Calif.). The following day, media was aspirated and replaced with serum-free Williams Media E (Life Technologies, Grand Island, N.Y.) containing 400 uM sodium dodecanoate (Sigma-Aldrich, St. Louis, Mo.). Forty minutes later, DGAT2 inhibitors (prepared as 100× stocks in 25% DMSO, 75% Williams' Media E) were added to the desired final concentration. All wells contained a selective DGAT1 inhibitor (Example 3, WO2009016462) at a concentration (3 uM) that completely suppressed endogenous DGAT1 activity. After a 20 minute preincubation, 0.2 uCi [1,3-14C]-glycerol (American Radio Chemicals, St. Louis, Mo.) was added to each well and mixed by gentle pipetting prior to a 3 hour incubation. At this point, media was aspirated and the cells were lysed in isopropyl alcohol:tetrahydrofuran (9:1) prior to centrifugation at 3000 rpm for 5 minutes. Radiolabeled lipids were resolved using a 2-solvent system by thin layer chromatography using standard technique (solvent 1 contained ethyl acetate: isopropyl alcohol: chloroform:methanol:0.25% potassium chloride in water (100:100:100:40.2:36.1, v/v/v/v) and solvent 2 contained hexane: diethyl ether: acetic acid (70:27:3, v/v/v)). After separation, radiolabeled lipids were visualized using a Molecular Dynamics' PhosphorImager system. The half maximal inhibitory concentrations (IC50 values) were determined using Graph Pad Prism (GraphPad Software, Inc., La Jolla, Calif.).	Homo sapiens	16	ALA3886612	cell-based format	BindingDB Database
3.	ALA4261855	B	Inhibition of human DGAT2	Homo sapiens	5	ALA4261487	single protein format	Scientific Literature
4.	ALA4261856	A	Drug metabolism in human liver microsomes assessed as UGT-mediated glucuronidation by measuring clearance rate	Homo sapiens	5	ALA4261487	microsome format	Scientific Literature
5.	ALA4261857	A	Drug metabolism in human liver microsomes assessed as CYP3A4-mediated oxidative metabolism by measuring clearance rate	Homo sapiens	5	ALA4261487	microsome format	Scientific Literature
6.	ALA4261858	B	Inhibition of rat DGAT2	Rattus norvegicus	2	ALA4261487	single protein format	Scientific Literature
7.	ALA4261859	B	Inhibition of dog DGAT2	Canis lupus familiaris	2	ALA4261487	single protein format	Scientific Literature
8.	ALA4261860	B	Inhibition of MGAT1 (unknown origin)	Homo sapiens	2	ALA4261487	single protein format	Scientific Literature
9.	ALA4261861	B	Inhibition of MGAT2 (unknown origin)	Homo sapiens	2	ALA4261487	single protein format	Scientific Literature
10.	ALA4261862	B	Inhibition of MGAT3 (unknown origin)	Homo sapiens	2	ALA4261487	single protein format	Scientific Literature
11.	ALA4261863	B	Inhibition of DGAT1 (unknown origin)	Homo sapiens	2	ALA4261487	single protein format	Scientific Literature
12.	ALA4261864	A	Apparent intrinsic clearance in human hepatocytes assessed per million cells	Homo sapiens	2	ALA4261487	cell-based format	Scientific Literature
13.	ALA4261865	A	Apparent intrinsic clearance in rat hepatocytes assessed per million cells	Rattus norvegicus	2	ALA4261487	cell-based format	Scientific Literature
14.	ALA4261866	A	Apparent intrinsic clearance in dog hepatocytes assessed per million cells	Canis lupus familiaris	2	ALA4261487	cell-based format	Scientific Literature
15.	ALA4261867	A	Drug metabolism in human liver microsomes assessed as fraction of UGT-mediated glucuronidation preincubated for 5 mins followed by addition of NADPH regenerating system and measured after 2.5 to 60 mins	Homo sapiens	2	ALA4261487	microsome format	Scientific Literature
16.	ALA4261868	A	Drug metabolism in human liver microsomes assessed as fraction of CYP3A4-mediated oxidative metabolism preincubated for 5 mins followed by addition of NADPH regenerating system and measured after 2.5 to 60 mins	Homo sapiens	2	ALA4261487	microsome format	Scientific Literature
17.	ALA4261869	A	Apparent permeability of the compound at pH 7.4		2	ALA4261487	assay format	Scientific Literature
18.	ALA4261870	P	Thermodynamic solubility of the compound at pH 6.5		2	ALA4261487	small-molecule physicochemical format	Scientific Literature
19.	ALA4261871	A	Fraction unbound in rat plasma	Rattus norvegicus	2	ALA4261487	cell-free format	Scientific Literature
20.	ALA4261872	A	Fraction unbound in dog plasma	Canis lupus familiaris	2	ALA4261487	cell-free format	Scientific Literature